Inflammation  >>  Tyzeka (telbivudine)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tyzeka (telbivudine) / Novartis
NCT00124241: An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B

Completed
2b
US, Canada, Europe, RoW
telbivudine, lamivudine
Novartis, Novartis Pharmaceuticals
Hepatitis B
02/03
11/05
NCT00128544: Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis B

Completed
2b
130
RoW
telbivudine, valtorcitabine
Novartis, Novartis Pharmaceuticals
Hepatitis B
05/07
05/07
NCT00804622: Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB)

Completed
2
15
RoW
telbivudine, tenofovir disproxil fumarate, telbivudine plus tenofovir disproxil fumarate
The University of Hong Kong, Novartis Pharmaceuticals
Chronic Hepatitis B
06/09
03/10
2016-004825-17: A Proof of concept study to investigate the effect of the antiviral medication "Telbivudine" in patients with inflammatory heart muscle disease caused by the Parvovirus Eine Machbarkeitsstudie über die Wirksamkeit des antiviralen Medikaments "Telbivudine" bei Patienten mit entzündlicher Herzmuskelerkrankung, die durch das Parvovirus verursacht ist

Ongoing
2
25
Europe
Sebivo, Tablet, Sebivo
Charité Universitätsmedizin Berlin, BMBF
Parvovirus B19-induced inflammatory cardiomyopathy Parvovirus B19-induzierte inflammatorische Kardiomyopathie, Parvovirus B19-induced inflammation of the heart muscle Parvovirus B19-ausgelöste Entzündung des Herzmuskels, Diseases [C] - Cardiovascular Diseases [C14]
 
 
NCT02338674: TDF and LdT in Immune-tolerant CHB Patients Awaiting Assisted Reproduction

Completed
1/2
121
RoW
Tenofovir and telbivudine, combination therapy, Tenofovir, single therapy
Fuzhou General Hospital
Hepatitis B, Chronic
10/16
10/17
CTHBVACADCHB, NCT02615639: A Clinical Trial on Hepatitis B Vaccine Activated-Dendritic Cells Combined With Anti-HBV Drugs in CHB

Unknown status
1/2
450
NA
HPDC-T cells & Entecavir, Hepatitis B Vaccine Activated-DCs & Entecavir, Entecavir, Baraclude, HPDC-T cells & IFN-a-2a, Hepatitis B Vaccine Activated-DCs & Pegasys, IFN-a-2a, Pegasys, HPDC-T cells & Telbivudine, Hepatitis B Vaccine Activated-DCs & Telbivudine, Telbivudine, LDT
Third Affiliated Hospital, Sun Yat-Sen University, Shanghai Jiao Tong University School of Medicine
Chronic Hepatitis B
11/18
11/18

Download Options